Cytosorbents Corp Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Cytosorbents Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Cytosorbents Corp Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.06M.
  • Cytosorbents Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $2.67M, a 26.5% decline year-over-year.
  • Cytosorbents Corp annual Nonoperating Income (Expense) for 2023 was $1.89M.
  • Cytosorbents Corp annual Nonoperating Income (Expense) for 2022 was -$2.38M, a 6.53% increase from 2021.
  • Cytosorbents Corp annual Nonoperating Income (Expense) for 2021 was -$2.55M, a 281% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.67M $2.06M +$3.91M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$1.24M -$724K -$1.13M -278% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$110K -$1.43M -$2M -353% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.89M $2.76M -$1.74M -38.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 $3.63M -$1.84M +$1.34M +42.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $2.29M $406K +$2.93M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$642K $566K +$1.74M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$2.38M $4.5M +$4.98M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$7.36M -$3.18M -$2.18M -218% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$5.18M -$2.52M -$2.77M -1120% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 -$2.41M -$1.18M +$140K +10.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$2.55M -$481K -$1.31M -158% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 -$1.24M -$1M -$2.12M -189% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $881K $247K -$184K -42.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $1.06M -$1.32M -$342K -35.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $1.41M $829K +$440K +113% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-09
Q3 2020 $966K $1.12M +$2.38M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$1.41M $431K +$348K +421% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$1.76M -$974K -$375K -62.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$1.38M $390K +$827K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 -$2.21M -$1.26M -$963K -328% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$1.25M $82.6K +$1.72M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$2.96M -$599K -$718K -602% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 -$2.25M -$437K -$419K -2253% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-09
Q3 2018 -$1.83M -$294K -$389K -410% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$1.44M -$1.63M -$2.23M -374% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $792K $119K +$86.5K +265% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $705K -$18.6K +$463K +96.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 $242K $94.8K +$139K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $103K $596K +$914K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$811K $32.6K -$221K -87.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$590K -$482K +$527K +52.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 -$1.12M -$43.9K +$653K +93.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$1.77M -$318K -$3.98M -109% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $2.21M $254K +$2.71M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$498K -$1.01M +$1.48M +59.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$1.98M -$697K -$682K -4611% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$1.3M $3.66M +$4.15M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$5.45M -$2.45M -$2.63M -1470% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$2.81M -$2.49M -$2.37M -1923% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-03
Q3 2014 -$449K -$14.8K +$70.1K +82.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$519K -$490K -$482K -5917% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$37K $179K +$386K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$423K -$123K -$6.59K -5.66% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$416K -$84.9K -$34.1K -67.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$382K -$8.15K +$29.7K +78.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$412K -$207K +$153K +42.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$564K -$116K +$112K +49% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$677K -$50.8K +$452K +89.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 -$1.13M -$37.8K +$189K +83.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$1.32M -$359K -$273K -317% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$1.04M -$229K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-03
Q3 2011 -$503K -$495K -6369% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-21
Q2 2011 -$227K -$225K -11842% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$86.1K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$7.78K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$1.9K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.